Peptide Library

In clinical trials

Brain & sleep

Trofinetide (predecessor programs)

Evidence

Clinical trials

Class

IGF-1 fragment peptides (GPE and analogs)

/

Trofinetide (predecessor programs)

KEY TAKEAWAY

This entry covers the earlier research on glycine-proline-glutamate (GPE), a natural fragment of IGF-1, and related analogs that led to trofinetide. These earlier compounds are not FDA-approved. Trofinetide (Daybue), the program that reached approval, treats Rett syndrome.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

IGF-1 fragment peptides (GPE and analogs)

Being studied for

Studied in brain injury and neurodegeneration models

Key fact

These earlier compounds are not FDA-approved. Trofinetide (Daybue), the program that reached approval, treats Rett syndrome.

Route

Varied by research program

Evidence strength

Clinical trials

What it is

What it is

This entry covers the earlier research on glycine-proline-glutamate (GPE), a natural fragment of IGF-1, and related analogs that led to trofinetide.

How it works

How it works

GPE and its analogs were studied for protecting nerve cells after injury and in neurodegenerative conditions, mostly in laboratory and animal models.

Regulatory status

Regulatory status

These earlier compounds are not FDA-approved. Trofinetide (Daybue), the program that reached approval, treats Rett syndrome.

What it is used for

What it is used for

Studied in brain injury and neurodegeneration models.

Side effects and risks

Side effects and risks

Because these programs were mostly preclinical or early phase, human safety data are limited.

Citations

Citations

Trofinetide (predecessor programs): see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo